P01.30 In vivo effects of isoform-specific inhibition of TGF-β(3) in glioblastoma

Introduction: Transforming growth factor (TGF)-β has been considered a therapeutic target in glioblastoma since decades. However, despite promising preclinical research data, the efficacy of TGF-β-targeted compounds in in vivo models and in clinical trials has been limited. Most recent approaches us...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Seystahl, K., Burghardt, I., Gramatzki, D., Schneider, H., Papachristodoulou, A., Hasenbach, K., Frei, K., Janicot, M., Roth, P., Weller, M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
POSTER PRESENTATIONS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463653/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.106
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge